Erratum: Author correction to "Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles" [Acta Pharmaceutica Sinica B 12 (2022) 1523-1533].

Abstract
[This corrects the article DOI: 10.1016/j.apsb.2021.09.004.].
Metadata
Date: 16 Nov 2023
DOI: 10.1016/j.apsb.2023.08.007
Journal: Acta pharmaceutica Sinica. B
Pubmed ID: 37969729
ML/Curated Information
Viruses: SARS-CoV-2
Article Type(s): Comment/Editorial
Topics: Model Systems & Tools